Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

ACG Plans Conyers, Georgia, Manufacturing Operations

10/30/2025
ACG, an integrated provider of solid-dosage solutions, plans to establish manufacturing operations in Conyers, Georgia. The $200 million project is expected to create more than 200 jobs.

The investment will include the construction of a new facility which will manufacture the outer shells for pills out of both gelatin and a plant-derived material known as HPMC, or hydroxypropyl methylcellulose, which has seen growing demand from vegetarians and in certain medications. Production is scheduled to begin in early 2027.

"Atlanta is the right location to execute at scale," said Selwyn Noronha, CEO, ACG Capsules. "Georgia and the City of Atlanta offer a pro-business environment, a strong talent pipeline, world-class connectivity, and reliable infrastructure. Combined with ACG's recent facility builds in Aurangabad (HPMC), Thailand (gelatin), and expansions in Brazil, Croatia and India, we have the operating discipline to begin production quickly and deliver reliable supply for North American customers."

ACG provides solid dosage products and services for the pharmaceutical and nutraceutical industries. The company manufactures hard-shell capsules, equipment, packaging materials, and inspection systems.

"ACG has served North America for over 25 years. This facility strengthens our ties with customers across the region—bringing us closer to them, enabling faster lead times, higher-quality service, and a more resilient, de-risked supply chain. Just as importantly, it lets us respond more quickly and co-develop new innovations through tighter R&D partnerships. It's been a long time coming, and we're glad to say it's here," noted Karan Singh, Managing Director, ACG.

Exclusive Research